New drug may offer safer treatment for dangerous virus in transplant patients
Disease control
Recruiting now
This study tests a new IV drug, brincidofovir, against the standard treatment cidofovir for adenovirus infection in children and adults who have had a stem cell transplant. Adenovirus can be serious in these patients because their immune system is weak. The goal is to see if the …
Phase: PHASE3 • Sponsor: SymBio Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 11:09 UTC